Joint replacement infections and osteomyelitis are among the most serious complications in orthopaedics and traumatology. The risk factors for these infections are often bacterial resistance to antimicrobials. One of the few solutions available to control bacterial resistance involves antimicrobials, which have a different mechanism of action from traditional antibiotics. Antimicrobial peptides (AMP) appear to be highly promising candidates in the treatment of resistant infections. We have identified several AMP in the venom of various wild bees and designed analogues that show potent antimicrobial activity and low toxicity against eukaryotic cells. The aim of the present study was to test the efficacy of one of those synthetic peptide analogues for the treatment of acute osteomyelitis invoked in laboratory rats. Femoral cavities of 20 laboratory Wistar rats were infected with Staphylococcus aureus. After 1 week, eight rats received an injectable calcium phosphate carrier alone, another eight rats were treated with a calcium phosphate mixed with AMP, and four rats were left without any further treatment. After another week, all rats were euthanized and radiographs were made of both the operated and healthy limbs. The animals with the carrier alone exhibited more severe acute osteomyelitis on radiographs in comparison to the recipients of the calcium phosphate carrier loaded AMP and untreated infected individuals. Based on the results of the above mentioned experiment, it was concluded that when injected directly into the site of femoral acute osteomyelitis, the calcium phosphate carrier mixed with AMP reduced osteomyelitis signs visible on radiographs.

Department of Orthopaedics 1st Faculty of Medicine Charles University Prague and Motol University Hospital 5 Úvalu 84 150 06 Prague 5 Czech Republic

Institute of Organic Chemistry and Biochemistry Academy of Sciences of the Czech Republic Flemingovo náměstí 2 166 10 Prague 6 Czech Republic

See more in PubMed

Clin Orthop Relat Res. 2005 Aug;(437):7-11 PubMed

J Med Microbiol. 2009 Aug;58(Pt 8):977-87 PubMed

Folia Microbiol (Praha). 2015 Sep;60(5):385-91 PubMed

Clin Orthop Relat Res. 2005 Aug;(437):111-4 PubMed

Antimicrob Agents Chemother. 2005 Jun;49(6):2438-44 PubMed

Acta Chir Orthop Traumatol Cech. 2006 Apr;73(2):108-14 PubMed

Biopolymers. 1998;47(6):451-63 PubMed

Biomatter. 2012 Oct-Dec;2(4):176-94 PubMed

Amino Acids. 2010 Aug;39(3):763-75 PubMed

Nature. 2002 Jan 24;415(6870):389-95 PubMed

J Antimicrob Chemother. 2004 Dec;54(6):1078-84 PubMed

Biomaterials. 2010 Sep;31(25):6363-77 PubMed

Cell Mol Life Sci. 2011 Jul;68(13):2161-76 PubMed

J Nat Prod. 2016 Apr 22;79(4):1073-83 PubMed

Biopolymers. 2005;80(6):717-35 PubMed

J Chemother. 2013 Apr;25(2):67-80 PubMed

Clin Orthop Relat Res. 2005 Aug;(437):59-66 PubMed

Clin Microbiol Rev. 2000 Oct;13(4):686-707 PubMed

Eur J Clin Microbiol Infect Dis. 2000 Jun;19(6):403-17 PubMed

J Mol Microbiol Biotechnol. 2011;20(4):228-35 PubMed

Trends Biotechnol. 2011 Sep;29(9):464-72 PubMed

Eur Cell Mater. 2014 Mar 25;27:196-212 PubMed

J Orthop Res. 1996 Nov;14(6):914-20 PubMed

Swiss Med Wkly. 2005 Apr 30;135(17-18):243-51 PubMed

Clin Infect Dis. 1997 Dec;25(6):1303-9 PubMed

Adv Exp Med Biol. 2015;830:29-46 PubMed

Nat Biotechnol. 2006 Dec;24(12):1551-7 PubMed

Int J Antimicrob Agents. 2011 Sep;38(3):217-25 PubMed

Cell Tissue Bank. 2006;7(4):319-23 PubMed

Clin Orthop Relat Res. 2005 Aug;(437):31-40 PubMed

J Antimicrob Chemother. 2004 Aug;54(2):472-6 PubMed

J Mol Med (Berl). 2007 Apr;85(4):317-29 PubMed

Acta Chir Orthop Traumatol Cech. 2008 Apr;75(2):88-92 PubMed

Pharmacol Rev. 2003 Mar;55(1):27-55 PubMed

N Engl J Med. 1991 Feb 28;324(9):601-12 PubMed

Antimicrobial Peptides for Topical Treatment of Osteomyelitis and Implant-Related Infections: Study in the Spongy Bone